He is a clinician-scientist. He was the founding Director of the McGill International TB Centre and led it from 2012 to 2018. He is the Director of the McGill Infectious Diseases Division and the McGill Interdisciplinary Initiative in Infection and Immunity (McGill-i4). Dr. Behr trained at the University of Toronto, Queen’s, McGill and Stanford. Dr. Behr’s work has helped clarify the natural history of TB, determined the basis of BCG attenuation, identified differences between closely related mycobacterial species and strains, and explained the molecular basis for the use of mycobacteria as immune adjuvants.